Delivery of siRNAs to cancer cells via bacteria

RNA Interference: Challenges and Therapeutic Opportunities

Volumn , Issue , 2014, Pages 171-129

  Ahmed, Omar ^a   Krühn, Andrea ^a   Lage, Hermann ^a  

^a Charité Campus Benjamin Franklin Medical Center   (Germany)

Author keywords

Bacteria; Cancer; RNA interference; shRNA; siRNA

Indexed keywords

EID: 84921877927     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4939-1538-5_7     Document Type: Chapter

References (22)

1. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391:806-811.
2. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494-498.
3. Hannon GJ (2002) RNA interference. Nature 418:244-251.
4. Dorsett Y, Tuschl T (2004) siRNAs: applications in functional genomics and potential as therapeutics. Nat Rev Drug Discov 3:318-329.
5. Martin SE, Caplen NJ (2007) Application of RNA interference in mammalian systems. Annu Rev Genomics Hum Genet 8:81-108.
6. Lage H (2009) Therapeutic potential of RNA interference in drug-resistant cancers. Fut Oncol 5:169-185.
7. Yang N-S, Burkholder J, Roberts B, Martinell B, McCabe D (1990) In vivo and in vitro gene transfer to mammalian cells by particle bombardment. Proc Natl Acad Sci U S A 87:9568-9572.
8. Furth PA, Shamay A, Wall RJ, Hennighausen L (1992) Gene transfer into somatic tissue by jet injection. Anal Biochem 205:365-368.
9. Sikes ML, O'Malley BW, Finegold MJ, Ledley FD (1994) In vivo gene transfer into rabbit thyroid follicular cells by direct DNA injection. Hum Gene Ther 6:837-844.
10. Aihara H, Miyazaki J-I (1998) Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 16:867-870.
11. Kanasty RL, Whitehead KA, Vegas AJ, Anderson DG (2012) Action and reaction: the biological response to siRNA and its delivery vehicles. Mol Ther 20:513-524.
12. Nguyen J, Szoka FC (2012) Nucleic acid delivery: the missing pieces of the puzzle? Acc Chem Res 17:1153-1162.
13. Kong Y, Ruan L, Ma L, Cui Y, Wang JM, Le Y (2007) RNA interference as a novel and powerful tool in immunopharmacological research. Int Immunopharmacol 7:417-426.
14. Beyerle A, Irmler M, Beckers J, Kissel T, Stoeger T (2010) Toxicity pathway focused gene expression profiling of PEI-based polymers for pulmonary applications. Mol Pharm 7:727-737.
15. Lage H, Fruehauf JH (2011) Delivery of therapeutic RNA molecules to cancer cells by bacteria. Ther Deliv 2:441-449.
16. Xiang S, Fruehauf J, Li CJ (2006) Short hairpin RNA-expressing bacteria elicit RNA interference in mammals. Nat Biotechnol 24:697-702.
17. Nguyen T, Fruehauf J (2008) Bacterial vectors for RNAi delivery. In: Slato R, Hill C (eds) Patho-biotechnology. Landes Bioscience and Springer Science, Austin, TX, pp 121-125
18. Lage H, Krühn A (2010) Bacterial delivery of RNAi effectors: transkingdom RNAi. J Vis Exp 42:2099, http://www.jove.com/details.stp? id=2099. doi: 10.3791/2099
19. Maizels NM (1973) The nucleotide sequence of the lactose messenger ribonucleic acid transcribed from the UV5 promoter mutant of Escherichia coli. Proc Natl Acad Sci U S A 70:3585-3589.
20. Bolduc GR, Fruehauf JH, Laroux FS, Sexton JA, Vaze MB (2011) WO 2010057009 A1
21. Jagielski M, Zaleska M, Kaluzwski S, Polna I (1976) Applicability of DAPI for the detection of mycoplasms in cell cultures. Med Dosw Mikrobiol 28:161-173.
22. Miliotis MD (1991) Acridine orange stain for determining intracellular enteropathogens in HeLa cells. J Clin Microbiol 29:830-831.